Cargando…

Fenofibrate: A Nonlithogenic Means of Recurrent Drug-Induced Pancreatitis

Medications account for a small portion of the various etiologies of acute pancreatitis. Prompt identification of drugs as the inciting factor decreases disease recurrence and unnecessary invasive diagnostic intervention. This case is a report of fenofibrate-induced acute pancreatitis including a di...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassim, Thamer, Hermes, Joy-Marie, Abdussalam, Abdullah, Aly, Ahmed, Chandra, Subhash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151234/
https://www.ncbi.nlm.nih.gov/pubmed/30271638
http://dx.doi.org/10.1155/2018/4580860
_version_ 1783357121797029888
author Kassim, Thamer
Hermes, Joy-Marie
Abdussalam, Abdullah
Aly, Ahmed
Chandra, Subhash
author_facet Kassim, Thamer
Hermes, Joy-Marie
Abdussalam, Abdullah
Aly, Ahmed
Chandra, Subhash
author_sort Kassim, Thamer
collection PubMed
description Medications account for a small portion of the various etiologies of acute pancreatitis. Prompt identification of drugs as the inciting factor decreases disease recurrence and unnecessary invasive diagnostic intervention. This case is a report of fenofibrate-induced acute pancreatitis including a disease recurrence with continuation of fenofibrate which subsequently resolved after drug discontinuation. The patient underwent invasive diagnostic evaluation including endoscopic ultrasound with fine needle aspiration and endoscopic retrograde cholangiopancreatography (ERCP). Based on exclusion of other disease etiologies and a positive drug rechallenge, fenofibrate fits as a class 1A medication in the classification of drug-induced pancreatitis.
format Online
Article
Text
id pubmed-6151234
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-61512342018-09-30 Fenofibrate: A Nonlithogenic Means of Recurrent Drug-Induced Pancreatitis Kassim, Thamer Hermes, Joy-Marie Abdussalam, Abdullah Aly, Ahmed Chandra, Subhash Case Rep Gastrointest Med Case Report Medications account for a small portion of the various etiologies of acute pancreatitis. Prompt identification of drugs as the inciting factor decreases disease recurrence and unnecessary invasive diagnostic intervention. This case is a report of fenofibrate-induced acute pancreatitis including a disease recurrence with continuation of fenofibrate which subsequently resolved after drug discontinuation. The patient underwent invasive diagnostic evaluation including endoscopic ultrasound with fine needle aspiration and endoscopic retrograde cholangiopancreatography (ERCP). Based on exclusion of other disease etiologies and a positive drug rechallenge, fenofibrate fits as a class 1A medication in the classification of drug-induced pancreatitis. Hindawi 2018-09-09 /pmc/articles/PMC6151234/ /pubmed/30271638 http://dx.doi.org/10.1155/2018/4580860 Text en Copyright © 2018 Thamer Kassim et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kassim, Thamer
Hermes, Joy-Marie
Abdussalam, Abdullah
Aly, Ahmed
Chandra, Subhash
Fenofibrate: A Nonlithogenic Means of Recurrent Drug-Induced Pancreatitis
title Fenofibrate: A Nonlithogenic Means of Recurrent Drug-Induced Pancreatitis
title_full Fenofibrate: A Nonlithogenic Means of Recurrent Drug-Induced Pancreatitis
title_fullStr Fenofibrate: A Nonlithogenic Means of Recurrent Drug-Induced Pancreatitis
title_full_unstemmed Fenofibrate: A Nonlithogenic Means of Recurrent Drug-Induced Pancreatitis
title_short Fenofibrate: A Nonlithogenic Means of Recurrent Drug-Induced Pancreatitis
title_sort fenofibrate: a nonlithogenic means of recurrent drug-induced pancreatitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151234/
https://www.ncbi.nlm.nih.gov/pubmed/30271638
http://dx.doi.org/10.1155/2018/4580860
work_keys_str_mv AT kassimthamer fenofibrateanonlithogenicmeansofrecurrentdruginducedpancreatitis
AT hermesjoymarie fenofibrateanonlithogenicmeansofrecurrentdruginducedpancreatitis
AT abdussalamabdullah fenofibrateanonlithogenicmeansofrecurrentdruginducedpancreatitis
AT alyahmed fenofibrateanonlithogenicmeansofrecurrentdruginducedpancreatitis
AT chandrasubhash fenofibrateanonlithogenicmeansofrecurrentdruginducedpancreatitis